University of Wisconsin, Madison: Carcinoma, Non-Small-Cell Lung trials
The registry lists 14 Carcinoma, Non-Small-Cell Lung studies with University of Wisconsin, Madison as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 5Phase 2 6No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HEARTS Trial for Thoracic CancersRecruitingNCT07132918Phase 2
- Improving Pulmonary Function Following Radiation TherapyCompletedNCT02843568Not applicableResults posted
- Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung CancerCompletedNCT01671332Phase 2Results posted
- Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung CancerCompletedNCT00798720Phase 2Results posted
- Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint InhibitionTerminatedNCT03275597Phase 1
- Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsCompletedNCT01999881Not applicable
- Feasibility Study: Comparison of Performance Status With Objective Physical Activity MonitorsTerminatedNCT01063400
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWithdrawnNCT01004419Phase 1
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung CancerCompletedNCT00954278Phase 1
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- NM404 as an Imaging Agent in Patients With NSCLCCompletedNCT00582283Phase 1
- Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
- Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerCompletedNCT00064012Phase 2
- Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung CancerStatus unknownNCT00004265Phase 2